Israel Used Dexamethasone To Treat Serious COVID-19 Cases Prior To British Study

1

JERUSALEM (VINnews) — After a British study published recently proved that an immune suppressor steroid called Dexamethasone could reduce deaths by up to one third in severely ill hospitalized patients, several Israeli hospitals including Sheba, Hadassah and Ichilov revealed that they had routinely treated seriously ill patients with the steroid even before the British trial was done.

Join our WhatsApp group

Subscribe to our Daily Roundup Email


Prof. Ronen Ben Ami, a specialist in internal medicine and infectious diseases at Ichilov hospital, told Ynet that there is an approach which says that one must treat the virus with medicines which reduce the body’s inflammatory response.

“The disease is a disease with inflammatory characteristics. Steroids are medications which can suppress the immune response,” Ben Ami says, adding that a number of patients who took the steroid did not require intubation. Despite this he stresses that “even though the rate of deaths in Israel was generally lower than other countries worldwide, I don’t know whether this is connected to Dexamethasone or not.”

 


Listen to the VINnews podcast on:

iTunes | Spotify | Google Podcasts | Stitcher | Podbean | Amazon

Follow VINnews for Breaking News Updates


Connect with VINnews

Join our WhatsApp group


1 Comment
Most Voted
Newest Oldest
Inline Feedbacks
View all comments
ANON21
ANON21
3 years ago

They did something right. Our “great” country and all of our “hero” doctors and nurses just now down to the stupid fda and cdc. So if a study shows something but it wasn’t done to the standards of the fda then everyone just lets people die. Those are our heroes. Nice.